Bio-Rad Laboratories
(BIO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 368,629 | 463,388 | 426,457 | 456,487 | 533,812 |
| Marketable Securities | 468,203 | 457,685 | 427,164 | 378,770 | 273,238 |
| Receivables | 377,548 | 398,739 | 375,800 | 373,817 | 387,619 |
| Inventories | 467,321 | 455,120 | 458,428 | 449,457 | 463,369 |
| Other current assets | 0 | 69,260 | 0 | 0 | 0 |
| TOTAL | $1,865,180 | $1,936,682 | $1,845,441 | $1,811,072 | $1,817,448 |
| Non-Current Assets | |||||
| PPE Net | 422,699 | 416,938 | 397,949 | 380,656 | 369,199 |
| Investments And Advances | 0 | 293,613 | 0 | 0 | 0 |
| Intangibles | 788,867 | 756,357 | 758,221 | 707,498 | 738,372 |
| Other Non-Current Assets | 380,057 | 39,913 | 301,405 | 269,669 | 262,855 |
| TOTAL | $1,591,623 | $1,506,821 | $1,457,575 | $1,357,823 | $1,370,426 |
| Total Assets | $3,456,803 | $3,443,503 | $3,303,016 | $3,168,895 | $3,187,874 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 119,340 | 130,867 | 113,282 | 119,448 | 109,571 |
| Accrued Expenses | 127,605 | 135,955 | 129,690 | 113,435 | 119,749 |
| Other current liabilities | 137,598 | 113,043 | 137,290 | 129,464 | 140,986 |
| TOTAL | $446,740 | $472,400 | $433,666 | $417,184 | $444,080 |
| Non-Current Liabilities | |||||
| Long Term Debt | 732,586 | 732,414 | 732,233 | 732,054 | 731,899 |
| Deferred Revenues | N/A | 26,288 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 246,239 | 108,174 | 201,648 | 166,943 | 171,910 |
| TOTAL | $978,846 | $955,563 | $933,868 | $899,219 | $903,748 |
| Total Liabilities | $1,425,586 | $1,427,963 | $1,367,534 | $1,316,403 | $1,347,828 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 28,528 | 28,499 | 28,366 | 28,299 | 28,244 |
| Common Shares | 3 | 3 | 3 | 3 | 3 |
| Retained earnings | 1,543,187 | 1,528,327 | 1,481,642 | 1,439,258 | 1,390,915 |
| Other shareholders' equity | 269,335 | 274,966 | 249,282 | 214,739 | 256,787 |
| TOTAL | $2,031,217 | $2,015,540 | $1,935,482 | $1,852,492 | $1,840,046 |
| Total Liabilities And Equity | $3,456,803 | $3,443,503 | $3,303,016 | $3,168,895 | $3,187,874 |